ESSENTIAL SKINCARE LLC has a total of 19 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, foods and drinks and organic fine chemistry are PROBI USA INC, MICROVASCULAR HEALTH SOLUTIONS LLC and XENO BIOSCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 6 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Enzymes | |
#4 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Kiss Zoltan | 19 |
Publication | Filing date | Title |
---|---|---|
EP1968628A2 | Transferrin and transferrin-based compositions for diabetes treatment | |
US2008044397A1 | Alkaline phosphatase compositions to reduce skin cancer | |
EP2061493A1 | Compositions to reduce or prevent skin cancer | |
EP1942928A2 | Protein composition for promoting wound healing and skin regeneration | |
US2007014777A1 | Protein compositions for promoting wound healing and skin regeneration | |
WO2005117937A2 | Alpha-1- acid glycoprotein for the treatment of diabetes | |
EP1696859A2 | Method for improving insulin sensitivity by administering an inhibitor of antitrypsin | |
US7374754B2 | Use of placental alkaline phosphatase to promote skin cell proliferation |